Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04890054 · ClinicalTrials.gov registry record · NA
Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC
A NA study, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 5,696
- Enrollment target
NCT04890054: Completed NA study, sponsored by OHSU Knight Cancer Institute.
NCT04890054 is a NA study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 5,696 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (306% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04890054, a NA study, has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,696 participants
- Enrollment target
Study Summary
This study collects information to provide a model for how to rapidly adapt and scale-up multilevel interventions through clinic-health plan partnerships to reduce the burden of colorectal cancer (CRC) on the United states population. This study may improve colorectal cancer screening rates, follow-up colonoscopy, and referral to care in rural Medicaid patients.
Primary Outcome
Adjusted 6-month any CRC screening for enrollees in clinic units. These values are predicted estimates rather than crude number \[%\] generated using marginal standardization and accounting for clustering and covariates (i.e., sex, age, and Medicaid health plan). Claims and vendor data were used to determine whether or not the patient completed CRC screening (i.e., fecal testing, FIT-DNA, sigmoidoscopy, CT colonography, or colonoscopy). To assess effectiveness of CRC screening completion, we use
Interventions
- OTHER Interview
- BEHAVIORAL Patient Navigation
- OTHER Fecal Immunochemical Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,696 participants |
| Start Date | 2021-05-14 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
What the finished NCT04890054 record still lists
NCT04890054 is an interventional study that assigns participants to a tested intervention. Its 5,696 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (306% higher).
The record links to 0 conditions, and to 3 interventions - of which Interview is the first listed.
NCT04890054 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04890054 about?
NCT04890054 is a clinical study titled "Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC". This study collects information to provide a model for how to rapidly adapt and scale-up multilevel interventions through clinic-health plan partnerships to reduce the burden of colorectal cancer (CRC) on the United states population. This study may improve colorectal cancer screening rates, follow-...
What is the current status of trial NCT04890054?
This trial is currently completed. It is a NA study. The enrollment target is 5,696 participants. The study started on 2021-05-14. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT04890054?
The interventions under investigation include: Interview (OTHER), Patient Navigation (BEHAVIORAL), Fecal Immunochemical Test (OTHER).
Who is sponsoring clinical trial NCT04890054?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04890054's enrollment target sits among peer trials
5,696 24th of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04983875 · 5,708 participants · NA
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
- NCT06627335 · 5,621 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- NCT05636176 · 5,600 participants · Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
- NCT06981598 · 5,586 participants · NA
Prevention of Psychological Health Problems Via Integrated Operational Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI